Dear GPC DROC and Dev Members, We have had 6 feasibility requests in the last two weeks. Please review the requests and submission details below. We really appreciate all of your contributions to these research efforts. Please reach out to me if you have any questions or concerns.
1. GPC DROC Request #60<https://protect-us.mimecast.com/s/VwFhCG62QouqpQZNs7Mxhy?domain=redcap.gpcnetwork.org> * Requestor: Dr. Kibum Kim * Topic: Acute Coronary Syndrome * Deadline: 4/17/2020 * Request#60 Submission Survey<https://protect-us.mimecast.com/s/34RhCJ627ruymDLWuzn0Iw?domain=redcap.kumc.edu> * Note: Dr. Kim has been modifying the code to address issues 2. GPC DROC Request #61<https://protect-us.mimecast.com/s/ayf5CKr25vF9vGxyuAd1wj?domain=redcap.gpcnetwork.org> * Requestor: Dr. Mei Liu * Topic: Identifying Personalized Risk of Acute Kidney Injury with Machine Learning * Query will be run on GROUSE so sites will not need to run the query locally. 3. GPC DROC Request #62<https://protect-us.mimecast.com/s/Q1TeCL925wFXpZMDTjb08F?domain=redcap.gpcnetwork.org> * Requestor: Dr. Xing Song * Topic: Multivariate Predictive Modeling to Optimize Triage Decision among COVID patients * Deadline: 4/17/2020 * Request#62 Submission Survey<https://protect-us.mimecast.com/s/t1VNCM825xu90AVyu1StIV?domain=redcap.kumc.edu> 4. GPC DROC Request #63<https://redcap.gpcnetwork.org/redcap_v9.5.16/DataEntry/index.php?pid=16&id=63&page=gpc_droc_oversight_request> * Requestor: Dr. Kibum Kim * Topic: Hemophilia treatment - extended and standard half life agents * Deadline: 4/30/2020 * Request#63 Submission Survey<https://redcap.kumc.edu/surveys/?s=CN8E4JXX8C> 5. GPC DROC Request #64<https://redcap.gpcnetwork.org/redcap_v9.5.16/DataEntry/index.php?pid=16&id=64&page=gpc_droc_oversight_request> * Requestor: Dr. Kibum Kim * Topic: JAK inhibitor use in patients with Rheumatoid Arthritis * Deadline: 4/30/2020 * Request#64 Submission Survey<https://redcap.kumc.edu/surveys/?s=4A4KT8CYLY> 6. GPC DROC Request #65<https://redcap.gpcnetwork.org/redcap_v9.5.16/DataEntry/index.php?pid=16&id=65&page=gpc_droc_oversight_request> * Requestor: Dr. Adam Bress * Topic: The association of angiotensin-converting-enzyme (ACE) inhibitor and angiotensin II receptor blocker (ARBs) use and severity of COVID-19 infection * Deadline: 04/16/2020 * Request#65 Submission Survey<https://redcap.kumc.edu/surveys/?s=44TCYTTANY> Thanks, Maren Lowrance Assistant Director of Product Design and Analysis Frontiers Informatics Navigator 913-588-7688
_______________________________________________ Gpc-dev mailing list Gpc-dev@listserv.kumc.edu http://listserv.kumc.edu/mailman/listinfo/gpc-dev
